Patents by Inventor Choon K. Oh

Choon K. Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
    Patent number: 7902378
    Abstract: The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: March 8, 2011
    Assignee: SmithKline Beecham (Cork) Limited
    Inventors: Christopher S. Brook, Wei Chen, Philip C. Dell'Orco, Lee M. Katrincic, Ann Marie Louvet, Choon K. Oh, Paul G. Spoors, Christopher Werner
  • Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
    Patent number: 7893100
    Abstract: The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: February 22, 2011
    Assignee: SB Pharmco Puerto Rico Inc.
    Inventors: Christopher S. Brook, Wei Chen, Philip C. Dell'Orco, Lee M. Katrincic, Ann Marie Louvet, Choon K. Oh, Paul G. Spoors, Christopher Werner
  • Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
    Patent number: 7759384
    Abstract: The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: July 20, 2010
    Assignee: SmithKline Beecham (Cork) Limited
    Inventors: Christopher S. Brook, Wei Chen, Philip C. Dell'orco, Lee M. Katrincic, Ann Marie Louvet, Choon K. Oh, Paul G. Spoors, Christopher Werner
  • Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
    Patent number: 7750036
    Abstract: The present invention relates to a salt of carvedilol and/or corresponding solvates thereof, compositions containing such carvedilol and/or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to carvedilol phosphate salts, and/or solvates thereof, which include a novel crystalline form of carvedilol dihydrogen phosphate (i.e., which is the dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.) and/or other corresponding solvates thereof, compositions containing these carvedilol phosphate salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: July 6, 2010
    Assignee: SB Pharmco Puerto Rico Inc.
    Inventors: Christopher S. Brook, Pingyun Y. Chen, Wei Chen, Qunying Dai, Philip C. Dell'Orco, Clifford S. Labaw, Ann Marie Diederich, Choon K. Oh, Claire Hisler, David H. Igo, Lee M. Katrincic, Li-Jen Ping, Paul G. Spoors, Jun Wang, Christopher Werner
  • Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
    Patent number: 7626041
    Abstract: The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: December 1, 2009
    Assignee: SmithKline Beecham (Cork) Ltd
    Inventors: Christopher S. Brook, Wei Chen, Philip C. Dell'orco, Lee M. Katrincic, Ann Marie Louvet, Choon K. Oh, Paul G. Spoors, Christopher Werner
  • CARVEDILOL PHOSPHATE SALTS AND/OR SOLVATES THEREOF, CORRESPONDING COMPOSITIONS, AND/OR METHODS OF TREATMENT
    Publication number: 20080262069
    Abstract: The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Application
    Filed: June 25, 2007
    Publication date: October 23, 2008
    Inventors: Christopher S. BROOK, Wei Chen, Phillip C. Dell'Orco, Lee M. Katrincic, Ann Marie Louvet, Choon K. Oh, Paul G. Spoors, Christopher Werner
  • Novel oral dosage form for carvedilol
    Publication number: 20040220250
    Abstract: The present invention discloses a matrix formulation containing carvedilol.
    Type: Application
    Filed: January 16, 2003
    Publication date: November 4, 2004
    Applicants: Boehringer Mannhein Pharmaceutical Corporation, SmithKline Beckman Corporation, Limited Partnership No. 1
    Inventor: Choon K. Oh
  • Novel composition of carvedilol
    Publication number: 20040186158
    Abstract: This invention relates to a novel composition of carvedilol and the use of such a composition in treatment of pediatric heart failure.
    Type: Application
    Filed: March 31, 2004
    Publication date: September 23, 2004
    Inventor: Choon K. Oh
  • Carvedilol polymorph
    Publication number: 20040152756
    Abstract: This invention relates to a novel crystalline from of Carvedilol, and to the use of pharmaceutical compositions thereof.
    Type: Application
    Filed: January 8, 2004
    Publication date: August 5, 2004
    Inventors: Wei Chen, Marc Galop, Choon K. Oh
  • Novel formulations of carvedilol
    Publication number: 20040019096
    Abstract: This invention relates to a novel formulations comprising carvedilol and methods of using these formulations to treat hypertension, congestive heart failure and angina.
    Type: Application
    Filed: April 23, 2003
    Publication date: January 29, 2004
    Inventors: Vlassios Andronis, Kimberly A Lamey, Choon K Oh
  • Novel oral dosage form for carvedilol
    Publication number: 20020182256
    Abstract: The present invention discloses a matrix formulation containing carvedilol.
    Type: Application
    Filed: May 8, 2002
    Publication date: December 5, 2002
    Applicant: Boehringer Mannheim Pharmaceutical Corporation -SmithKline Beckman Corporation
    Inventor: Choon K. Oh
  • Novel oral dosage form for carvedilol
    Publication number: 20020054911
    Abstract: The present invention discloses a matrix formulation containing carvedilol.
    Type: Application
    Filed: October 9, 2001
    Publication date: May 9, 2002
    Applicant: Boehringer Mannheim Pharmaceutical Corporation-Sm ithKline Beckman Corporation, Limited Partnershi
    Inventor: Choon K. Oh